Association between the angiotensin-converting enzyme (insertion/deletion) and angiotensin II type 1 receptor (A1166C) polymorphisms and breast cancer among Brazilian women
Restricted accessOtherFirst published online March, 2009
Association between the angiotensin-converting enzyme (insertion/deletion) and angiotensin II type 1 receptor (A1166C) polymorphisms and breast cancer among Brazilian women
Introduction.We evaluated the association between components of the renin-angiotensin system and the development of breast cancer in a case-control study by means of angiotensin-converting enzyme (ACE) insertion/deletion (I/D) and angiotensin II type 1 (AT 1)-receptor A1166C polymorphisms.
Methods. Genotyping was performed by PCR-RFLP (restriction fragment length polymorphism) or PCR (polymerase chain reaction) using genomic DNA extracted from buccal cells of subjects with (101 cases) or without (307 controls) breast cancer.
Results.The frequencies of genotypes for ACE were: DD, ID and II (in %: cases: 60; 20; 20; controls: 46; 37; 17; p=0.019, χ2); and for AT1receptor were:AA,AC and CC (in %: cases: 65; 30; 5; controls: 51; 44; 5; p=0.114, χ 2).The results suggested that the A1166C polymorphism was not associated with breast cancer risk. On the other hand, for the ACE (I/D), there seemed to be different risks for cancer between cases and controls.
Conclusions.The ID genotype was less frequently associated with the disease than were the DD or II; that is, women with the ID genotype were 3.1 times less likely to develop breast cancer than those with the other genotypes.The ID genotype might be protective against breast cancer and the ACE (I/D) polymorphism a possible target for developing genetic markers for breast cancer.
Sayed-Tabatabaei FA, Oostra BA, Isaacs A., van Duijn CM, Witteman JCM..ACE polymorphisms . Circ Res2006;98:1123-33.
2.
de Gasparo M. , Catt KJ, Inagami T., Wright JW, Unger T.International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev2000;52:415-72.
3.
Wolf G., Ziyadeh FN, Helmchen U., Zahner G., Schroeder R., Stahl RAANG II is a mitogen for a murine cell line isolated from medullary thick ascending limb of Henle's loop. Am J Physiol1995;268:F940-7.
4.
Stoll M., Meffert S., Stroth U., Unger T.Growth or anti-growth: angiotensin and the endothelium. J Hypertens1995;13:1529-34.
5.
Tian Y., Balla T., Baukal AJ, Catt KJGrowth responses to angiotensin II in bovine adrenal glomerulosa cells. Am J Physiol1995;268:E135-44.
6.
Fujita M., Hayashi I., Yamashina S., Itoman M., Majima M.Blockade of angiotensin AT1a receptor signaling reduces tumor growth, angiogenesis, and metastasis. Biochem Biophys Res Commun2002;294:441-7.
7.
Muscella A., Greco S., Elia MG, Storelli C., Marsigliante S.Angiotensin II stimulation of Na+/K+ATPase activity and cell growth by calcium-independent pathway in MCF-7 breast cancer cells. J Endocrinol2002;173:315-23.
8.
Nakajima M., Hutchinson HG, Fujinaga M. et al. The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain of function study using in vivo gene transfer . Proc Natl Acad Sci U S A1995;92:10663-7.
9.
De Paepe B., Verstraeten VL, De Potter CR, Vakaet LA, Bullock GRIncreased angiotensin II type-2 receptor density in hyperplasia. DCIS and invasive carcinoma of the breast is paralleled with increased iNOS expression . Histochem Cell Biol2002;116:247-54.
10.
Inwang ER, Puddefoot JR, Brown CL et al. Angiotensin II type 1 receptor expression in human breast tissues . Br J Cancer1997;75:1279-83.
11.
Marsigliante S., Resta L., Muscella A., Vinson GP, Marzullo A., Storelli C.AT1 angiotensin II receptor subtype in the human laryns and squamous laryngeal carcinoma. Cancer Lett1996; 110(1-2):19-27.
12.
Takeda H., Kondo S.Differences between squamous cell carcinoma and keratoacanthoma in angiotensin type-1 receptor expression. Am J Pathol2001 ;158:1633-7.
13.
Rigat B., Hubert C., Alhenc-Gelas F., Cambien F., Corvol F., Soubrier FJAn insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. Clin Invest1990;86:1343-6.
14.
Curnow KM, Pascoe L., White PCGenetic analysis of the human type-1 angiotensin II receptor. Mol Endocrinol1992;6:1113-18.
15.
Davies E., Bonnardeaux A., Lathrop GM, Corvol P., Clauser E., Soubrier F.Angiotensin II (type I) receptor locus: CA repeat polymorphism and genetic mapping. Hum Mol Genet1994;3:83-4.
16.
Furuta H., Guo DF, Inagami T.Molecular cloning and sequencing of the gene encoding human angiotensin II type 1 receptor. Biochem Biophys Res Commun1992;183:8-13.
17.
Bonnardeaux A., Davies E., Jeunemaitre X. et al. Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. Hypertension1994;24:63-9.
18.
Castellano M., Muiesan ML, Beschi M. et al. Angiotensin II type 1 receptor A/C1166 polymorphism: relationships with blood pressure and cardiovascular structure . Hypertension1996 ;28:1076-80.
19.
Amant C., Hamon M., Bauters C. et al. The angiotensin II type 1 receptor gene polymorphism is associated with coronary artery vasoconstriction. J Am Coll Cardiol1997; 29:486-90.
20.
Talamine R. , Franceschi S., Favero A., Negri E., Parazzini F., La Vecchia C.Selected medical conditions and risk of breast cancer. Br J Cancer1997;75:1699-703.
21.
Peeters PH, van Noord PA, Hoes AW, Fracheboud J., Gimbrere CH, Grobbee DEHypertension and breast cancer risk in a 19-year follow-up study (the DOM cohort). Diagnostic investigation into mammarian cancer. J Hypertens2000;18:249-54.
22.
Mack TM, Henderson BE, Gerkins VR, Arthur M., Baptista J., Pike MCReserpine and breast cancer in a retirement community. N Engl J Med1975;292:1366-71.
23.
Lever AF, Hole DJ, Gillis CR et al. Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer?Lancet1998;352:179-84.
24.
Meier CR, Derby LE, Jick SS, Jick H.Angiotensin-converting enzyme inhibitors, calcium channel blockers, and breast cancer. Arch Intern Med2000;160:349-53.
25.
Koh WP, Yuan JM, Sun CL et al. Angiotensin I-converting enzyme (ACE) gene polymorphism and breast cancer risk among Chinese women in Singapore. Cancer Res2003;63:573-8.
26.
Haiman CA, Henderson SO, Bretsky P., Kolonel LN, Henderson BEGenetic variation in angiotensin I-converting enzyme (ACE) and breast cancer risk: the multiethnic cohort. Cancer Res2003 ;63:6984-7.
27.
Freitas-Silva M., Pereira D., Coelho C., Bicho M., Lopes C., Medeiros R.Angiotensin I converting enzyme gene insertion/ deletion polymorphism and endometrial human cancer in normotensive and hypertensive women. Cancer Genet Cytogenet2004;155:42-6.
28.
Correa SAA , Franca LP, Costa-Neto CM, Oliveira L., Paiva AC, Shimuta SIRelevant role of Leu265 in helix VI of the angiotensin AT1 receptor in agonist binding and activity. Can J Physiol Pharmacol2002;80:426-30.
29.
Correa SAA , Zalcberg H., Han SW et al. Aliphatic amino acids in helix VI of the AT1 receptor play a relevant role in agonist binding and activity. Regul Pept2002;106:33-8.
30.
Correa SAA , Pacheco NAS , Costa-Neto CM et al. New mutants of angiotensin II AT1 receptor expressed in CHO cells caused morphological change and inhibition of cell growth. Regul Pept2005;131:18-22.
31.
Koh WP, Yuan JM, Van Den Berg D., Lee HP, Yu MCPolymorphisms in angiotensin II type 1 receptor and angiotensin I-converting enzyme genes and breast cancer risk among Chinese women in Singapore. Carcinogenesis2005;26:459-64.
32.
Szombathy T. , Jánoskúti L., Szalai C. et al. Angiotensin II type 1 receptor gene polymorphism and mitral valve prolapse syndrome. Am Heart J2000;139:101-5.
33.
Fukazawa R. , Sonobe T., Hamamoto K. et al. Possible synergic effect of angiotensin-I converting enzyme gene insertion/ deletion polymorphism and angiotensin-II type-1 receptor 1166A/C gene polymorphism on ischemic heart disease in patients with Kawasaki disease. Pediatr Res2004;56:597-601.
34.
Wang JG, Staessen JAGenetic polymorphisms in the renin-angiotensin system: relevance for susceptibility to cardiovascular disease. Eur J Pharmacol2000;410:289-302.
35.
Lee EJPopulation genetics of the angiotensin-converting enzyme in Chinese . Br J Clin Pharmacol1994;37:212-14.
Sanderson JE , Young RP, Yu CM, Chan S., Critchley JA, Woo KSLack of association between insertion/deletion polymorphism of the angiotensin converting enzyme gene and end-stage heart failure due to ischemic or idiopathic dilate cardiomyopathy in the Chinese . Am J Cardiol1996;77:1008-10. 38. Young RP, Thomas GN, Critchley JA, Tomlinson B., Woo KS, Sanderson JEInterethnic differences in coronary heart disease mortality in 25 populations: association with the angiotensin-converting enzyme DD genotype frequency. J Cardiovasc1998;5:303-7.
38.
Méthot J., Hamelin BA, Arsenault M., Bogaty P., Plante S., Poirier P.The ACE-DD genotype is associated with endothelial dysfunction in postmenopausal women. Menopause2006; 13:959-66.
